GJB2-Related Hearing Loss: Genotype-Phenotype Correlations, Natural History, and Emerging Therapeutic Strategies
International Journal of Molecular Sciences · 03.01.2026 · 27 (1) · 491
DOI: 10.3390/ijms27010491 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.01.2026. Verfasst von Julia Anne Morris und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Connexin 26, Genetic Association Studies, Hearing Loss, Connexins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NIH USA, National Institute of Health USA.
Abstract (Originalsprache)
This review integrates molecular, clinical, and translational data to provide an updated understanding of GJB2-related deafness and its emerging treatment landscape. Truncating mutations in GJB2 typically cause severe-profound hearing loss (HL) phenotypes, whereas non-truncating alleles are often associated with milder or progressive phenotypes. Geographic variation in variant prevalence contributes to regional differences in disease burden. Beyond the coding region, deletions and cis-regulatory mutations within the DFNB1 locus, including GJB6 and CRYL1, can influence HL severity when compounded with other pathogenic GJB2 variants. DFNB1 hearing loss generally presents as symmetric, bilateral, and flat to gently sloping across frequencies, with preserved cochlear neurons that support excellent cochlear implant (CI) outcomes. Early implantation CI in GJB2-positive children yields superior speech and language development compared with non-GJB2 etiologies. Emerging therapies include dual-AAV (AAV1 + AAV-ie/ScPro) delivery, achieving cell-specific Cx26 restoration, adenine base-editing for dominant-negative variants, and allele-specific suppression using RNA interference or antisense oligonucleotides. Concurrent progress in human iPSC-derived cochlear organoids provides a physiologic model to advance toward clinical trials. By integrating genotype-phenotype correlations, natural history insights, and advances in molecular therapeutics, this review presents a comprehensive update on GJB2-related HL and highlights how gene-based strategies are poised to change the treatment of this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
- Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
ORCID-Profile: Julia Anne Morris, Susan H Blanton, Xue Zhong Liu
Förderung
- NIDCD NIH HHS
- NIH USA
- National Institute of Health USA
- National Institutes of Health
- U.S. Department of Defense Hearing Restoration Research Program
Zitieren
APA
Morris, J. A., Gonzalez, T., Blanton, S. H., Angeli, S. I., & Liu, X. Z. (2026). GJB2-Related Hearing Loss: Genotype-Phenotype Correlations, Natural History, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences, 27(1), 491. https://doi.org/10.3390/ijms27010491
Vancouver
Morris JA, Gonzalez T, Blanton SH, Angeli SI, Liu XZ. GJB2-Related Hearing Loss: Genotype-Phenotype Correlations, Natural History, and Emerging Therapeutic Strategies. International Journal of Molecular Sciences. 2026;27(1):491. doi:10.3390/ijms27010491
BibTeX
@article{Morris2026,
author = {Morris, Julia Anne and Gonzalez, Tomas and Blanton, Susan H and Angeli, Simon Ignacio and Liu, Xue Zhong},
title = {GJB2-Related Hearing Loss: Genotype-Phenotype Correlations, Natural History, and Emerging Therapeutic Strategies},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {1},
pages = {491},
doi = {10.3390/ijms27010491}
}
EUVIMED